The peptide is believed to promote slow wave sleep and improve sleep quality without the sedative drawbacks of traditional sleep medications
Biological function of the BBB The BBB is a physical and biochemical barrier that precisely regulates environmental homeostasis in brain tissue
declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche
Both companies operate in a high-growth oligopoly, effectively dividing the GLP-1 market between them, with Novo holding around 55% of the global market, while Eli Lilly has secured 45%